Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Cobo-Calvo

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
JAMA Network Open|April 12, 2024
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With NatalizumabRené Carvajal, Ana Zabalza, Pere Carbonell-Mirabent, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2019
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric studyJonathan Ciron, Alvaro Cobo-Calvo, Bertrand Audoin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 5, 2025
Uncovering alternative diagnoses in patients with clinical syndromes suggestive of multiple sclerosis: A transversal study from the prospective Barcelona CIS cohortAndreu Vilaseca, Mar Tintoré, Pere Carbonell-Mirabent, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 5, 2016
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatusMaria Sepúlveda, Thaís Armangué, Nuria Sola-Valls, et al.
Neurology|April 27, 2018
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR studyAlvaro Cobo-Calvo, Anne Ruiz, Elisabeth Maillart, et al.
Neurology|February 4, 2025
Age-Related Disability Outcomes After a First Demyelinating EventAlvaro Cobo-Calvo, Pere Carbonell-Mirabent, Carmen Tur, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 2, 2022
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple SclerosisAna Zabalza, Georgina Arrambide, Paula Tagliani, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 28, 2024
Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum DisordersFrederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
The Lancet. Neurology|August 21, 2021
Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Yael Hacohen, Alvaro Cobo-Calvo, et al.
Brain : a Journal of Neurology|December 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisGéraldine Androdias, Jan D Lünemann, Elisabeth Maillart, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
JAMA Network Open|April 12, 2024
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With NatalizumabRené Carvajal, Ana Zabalza, Pere Carbonell-Mirabent, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2019
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric studyJonathan Ciron, Alvaro Cobo-Calvo, Bertrand Audoin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 5, 2025
Uncovering alternative diagnoses in patients with clinical syndromes suggestive of multiple sclerosis: A transversal study from the prospective Barcelona CIS cohortAndreu Vilaseca, Mar Tintoré, Pere Carbonell-Mirabent, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 5, 2016
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatusMaria Sepúlveda, Thaís Armangué, Nuria Sola-Valls, et al.
Neurology|April 27, 2018
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR studyAlvaro Cobo-Calvo, Anne Ruiz, Elisabeth Maillart, et al.
Neurology|February 4, 2025
Age-Related Disability Outcomes After a First Demyelinating EventAlvaro Cobo-Calvo, Pere Carbonell-Mirabent, Carmen Tur, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 2, 2022
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple SclerosisAna Zabalza, Georgina Arrambide, Paula Tagliani, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 28, 2024
Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum DisordersFrederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
The Lancet. Neurology|August 21, 2021
Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Yael Hacohen, Alvaro Cobo-Calvo, et al.
Brain : a Journal of Neurology|December 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisGéraldine Androdias, Jan D Lünemann, Elisabeth Maillart, et al.
Pageof 5